Aetion eBook Highlights the Impact of RWE in Successful Drug Approvals Ahead of FDA Framework

Aetion has published an eBook detailing how real world data (RWD) and real world evidence (RWE) can impact drug approvals by the Food and Drug Administration (FDA). The eBook includes case studies where RWE led to the approval of drugs and biologics. The guide also compares RWE use in 10 areas of study, including oncology and neuroscience drug approvals.

“Aetion’s comprehensive eBook—updated for 2021 with new data and case studies—is designed to help inform your RWE strategy, guiding you through when, where, and how RWE studies have supported FDA decisions.” Access the complete eBook here.

(Source: Aetion, 10/2021)